RARRES3 anticorps (AA 69-134)

N° du produit ABIN1886616

Cet anticorps anti-RARRES3 Polyclonal Lapin (ABIN1886616) détecte spécifiquement RARRES3 dans WB. L’anticorps est réactif avec des échantillons de Humain.

Aperçu rapide pour RARRES3 anticorps (AA 69-134) (ABIN1886616)

Antigène: RARRES3 (Retinoic Acid Receptor Responder (Tazarotene Induced) 3 (RARRES3))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp RARRES3 est non-conjugé

Application: Western Blotting (WB)

Détail du produit anti-RARRES3 anticorps

Épitope: AA 69-134

Purification: Purified by antigen-affinity chromatography.

Immunogène: Synthetic peptide contain a sequence corresponding to a region within amino acids 69 and 134 of Human RARRES3

Information d'application

Indications d'application: Suggested dilutions:
Western blotting: 1.500-1.3000

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.

Agent conservateur: Thimerosal (Merthiolate)

Précaution d'utilisation: Biohazard Informations: This product contains thimerosal which is hazardous.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.

Détails sur RARRES3

Antigène: RARRES3 (Retinoic Acid Receptor Responder (Tazarotene Induced) 3 (RARRES3))

Autre désignation: RARRES3

Sujet: Retinoids exert biologic effects such as potent growth inhibitory and cell differentiation activities and are used in the treatment of hyperproliferative dermatological diseases.These effects are mediated by specific nuclear receptor proteins that are members of the steroid and thyroid hormone receptor superfamily of transcriptional regulators.RARRES1, RARRES2, and RARRES3 are genes whose expression is upregulated by the synthetic retinoid tazarotene.RARRES3 is thought act as a tumor suppressor or growth regulator.[provided by RefSeq]

Poids moléculaire: 18 kDa

ID gène: 5920

NCBI Accession: NP_004576, NM_004585